Short answer
SUPERNUS PHARMACEUTICALS, INC. (SUPN) filed an 8-K current report with the SEC on June 18, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Shareholders elected Frederick M. Hudson and Charles W. Newhall III as Class I directors through 2029.
SUPERNUS PHARMACEUTICALS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Shareholders elected Frederick M. Hudson and Charles W. Newhall III as Class I directors through 2029
- Executive compensation received advisory approval with 45,552,633 votes for
- KPMG LLP auditor appointment ratified decisively with 49,882,228 votes for
- 2021 Equity Incentive Plan share increase approved with 41,925,692 votes for, enabling additional equity awards
- 3,073,181 broker non-votes affected director, compensation, and equity-plan proposals
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SUPERNUS PHARMACEUTICALS, INC. 8-K filings
Get the next SUPN 8-K as it lands
Follow SUPN for push alerts, or ask the research agent what this filing means.